Variants of uncoupling protein-2 gene and obesity: Interaction with peroxisome proliferator-activated receptorγ2

Clinical Endocrinology

Volumn 59, Issue 6, 2003, Pages 817-822

  Mancini, Francesco P ^a,b,c   Sabatino, Lina ^a   Colantuoni, Vittorio ^a,b   Pasanisi, Fabrizio ^b   Finelli, Carmine ^b   Contaldo, Franco ^b   Masulli, Maria ^b   Riccardi, Gabriele ^b   Vaccaro, Olga ^b  

^a UNIVERSITY OF SANNIO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCOUPLING PROTEIN 2;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD GLUCOSE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN; ION CHANNELS; LIPIDS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0344082604     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01926.x     Document Type: Article

References (34)

1. Argilés, J.M., Busquets, S. & López-Soriano, F.J. (2002) The role of uncoupling proteins in pathophysiological states. Biochemical and Biophysical Research Communications, 293, 1145-1152.
2. Aubert, J., Champigny, O., Saint-Marc, P., Negrel, R., Collins, S., Ricquier, D. & Ailhaud, G. (1997) Upregulation of UCP-2 gene expression by PPAR agonists in preadipose and adipose cells. Biochemical and Biophysical Research Communications, 238, 606-611.
3. Beamer, B.A., Yen, C.-J., Andersen, R.E., Muller, D., Elahi, D., Cheskin, L.J., Andres, R., Roth, J. & Shuldiner, A.R. (1998) Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations. Diabetes, 47, 1806-1808.
4. Bonora, E., Targher, G., Alberiche, M., Bonadonna, R., Saggiani, F., Zenere, M., Monauni, T. & Muggeo, M. (2000) Homeostasis Model Assessment closely mirrors the glucose clamp technique in assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23, 57-63.
5. Boss, O., Hagen, T. & Lowell, B.B. (2000) Uncoupling proteins 2 and 3. Potential regulators of mitochondrial energy metabolism. Diabetes, 49, 143-156.
6. Chan, C.B., De Leo, D., Joseph, J.W., McQuaid, T.S., Ha, X.F., Xu, F., Tsushima, R.G., Pennefather, P.S., Salapatek, A.M.F. & Wheeler, M.B. (2001) Increased uncoupling protein-2 levels in β-cells are associated with impaired glucose-stimulated insulin secretion. Mechanism of action. Diabetes, 50, 1302-1310.
7. Chevillotte, E., Rieusset, J., Roques, M., Desage, M. & Vidal, H. (2001) The regulation of uncoupling protein-2 gene expression by ω-6 polyunsaturated fatty acids in human skeletal muscle cells involves multiple pathways, including the nuclear receptor peroxisome proliferator-activated receptor β. Journal of Biological Chemistry, 276, 10853-10860.
8. Clapham, J.C., Arch, J.R.S., Chapman, H., Haynes, A., Lister, C., Moore, G.B., Piercy, V., Carter, S.A., Lehner, I., Smith, S.A., Beeley, L.J., Godden, R.J., Herrity, N., Skehel, M., Changani, K.K., Hockings, P.D., Reid, D.G., Squires, S.M., Hatcher, J., Trail, B., Latcham, J., Rastan, S., Harper, A.J., Cadenas, S., Buckingham, J.A., Brand, M.D. & Abuin, A. (2000) Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature, 406, 415-418.
9. Dalgaard, L.T. & Pedersen, O. (2001) Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia, 44, 946-965.
10. Deeb, S.S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W. & Auwerx, J. (1998) A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics, 20, 284-287.
11. Desvergne, B. & Wahli, W. (1999) Peroxisome Proliferator-Activated Receptors: nuclear control of metabolism. Endocrine Reviews, 20, 649-688.
12. Echtay, K.S., Roussel, D., St-Pierre, J., Jekabsons, M.B., Cadenas, S., Stuart, J.A., Harper, J.A., Roebuck, S.J., Morrison, A., Pickering, S., Clapham, J.C. & Brand, M.D. (2002) Superoxide activates mitochondrial uncoupling proteins. Nature, 415, 96-99.
13. Ek, J., Urhammer, S.A., Sørensen, T.I.A., Andersen, T., Auwerx, J. & Pedersen, O. (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia, 42, 892-895.
14. El-Deriny, S., Ng, R.H. & Statland, B.E. (1986) Evaluation of the Kodak Ektachem DT-60 analyzer. Clinical Chemistry, 32, 415-419.
15. Esterbauer, H., Schneitler, C., Oberkofler, H., Ebenbichler, C., Paulweber, B., Sandhofer, F., Ladurner, G., Hell, E., Strosberg, D.A., Patsch, J.R., Krempler, F. & Patsch, W. (2001) A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nature Genetics, 28, 178-183.
16. Hsueh, W.-C., Shelley, C.A., Shuldiner, A.R., Blangero, J., Hixson, J.E., MacCluer, J.W. & Mitchell, B.D. (2001) Interactions between variants in the β3-adrenergic receptor and peroxisome proliferator-activated receptor-γ2 genes and obesity. Diabetes Care, 24, 672-677.
17. Lanni, A., Mancini, F.P., Sabatino, L., Silvestri, E., Franco, R., De Rosa, G., Goglia, F. & Colantuoni, V. (2002) De novo expression of uncoupling protein 3 is associated to enhanced mitochondrial thioesterase-1 expression and fatty acid metabolism in liver of fenofibrate-treated rats. FEBS Letters, 525, 7-12.
18. Mancini, F.P., Vaccaro, O., Sabatino, L., Tufano, A., Rivellese, A., Riccardi, G. & Colantuoni, V. (1999) Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes. Diabetes, 48, 1466.
19. Mancini, F.P., Lanni, A., Sabatino, L., Moreno, M., Giannino, A., Contaldo, F., Colantuoni, V. & Goglia, F. (2001) Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Letters, 491, 154-158.
20. Marotta, G., Auletta, P., Liguori, M., Turbati, M., Riccardi, G. & Vaccaro, O. (1994) Uso della chimica a secco in una campagna per l'identificazione dei fattori di rischio per le malattie cardiovascolari. Epidemiologia E Prevenzione, 18, 224-229.
21. Mattheus, D.P., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.N. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentration in man. Diabetologia, 28, 412-419.
22. Miller, S.A., Dykes, D.D. & Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
23. Mori, Y., Kim-Motoyama, H., Katakura, T., Yasuda, K., Kadowaki, H., Beamer, B.A., Shuldiner, A.R., Akanuma, Y., Yazaki, Y. & Kadowaki, T. (1998) Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochemical and Biophysical Research Communications, 251, 195-198.
24. Rankinen, T., Pérusse, L., Weisnagel, J.S., Snyder, E., Chagnon, Y.C. & Bouchard, C. (2002) The human obesity gene map: the 2001 update. Obesity Research, 10, 196-243.
25. Ricquier, D. & Bouillaud, F. (2000) The uncoupling protein homologues: UCPl, UCP2, UCP3, StUCP and AtUCP. Biochemical Journal, 345, 161-179.
26. Rieusset, J., Auwerx, J. & Vidal, H. (1999) Regulation of gene expression by activation of the peroxisome proliferator-activated receptor with rosiglitazone (BRL 49653) in human adipocytes. Biochemical and Biophysical Research Communications, 265, 265-271.
27. Rosenbaum, M., Leibel, R.L. & Hirsch, J. (1997) Obesity. New England Journal of Medicine, 337, 396-401.
28. Roth, J., & Gorden, P. Clinical application of the insulin assay. Amsterdam: North. Holland Publishing Co. (1973).
29. Schonfeld-Warden, N.A. & Warden, C.H. (2001) Physiological effects of variants in human uncoupling proteins: UCP2 influences body-mass index. Biochemical Society Transactions, 29, 777-784.
30. Vaccaro, O., Mancini, F.P., Ruffa, G., Sabatino, L., Iovine, C., Masulli, M., Colantuoni, V. & Riccardi, G. (2002) Fasting plasma free fatty acid concentrations and Pro12Ala polymorphism of the peroxisome proliferator- activated receptor (PPAR) γ2 gene in healthy individuals. Clinical Endocrinology, 57, 481-486.
31. Vidal-Puig, A.J., Grujic, D., Zhang, C.-Y., Hagen, T., Boss, O., Ido, Y., Szczepanik, A., Wade, J., Mootha, V., Cortright, R., Muoio, D.M. & Lowell, B.B. (2000) Energy metabolism in uncoupling protein 3 gene knockout mice. Journal of Biological Chemistry, 275, 16258-16266.
32. Viguerie-Bascands, N., Saulnier-Blache, J.S., Dandine, M., Dauzats, M., Daviaud, D. & Langin, D. (1999) Increase in Uncoupling Protein-2 mRNA expression by BRL49653 and bromopalmitate in human adipocytes. Biochemical and Biophysical Research Communications, 256, 138-141.
33. WHO. (1997) Report of a WHO Consultation on Obesity. Obesity: Preventing and Managing the Global Epidemic. World Health Organization, Geneva.
34. Zhang, C.-Y., Baffy, G., Perret, P., Krauss, S., Peroni, O., Grujic, D., Hagen, T., Vidal-Puig, A.J., Boss, O., Kim, Y.-B., Zheng, X.X., Wheeler, M.B., Shulman, G.I., Chan, C.B. & Lowell, B.B. (2001) Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell, 105, 745-755.